NCT07215715View on ClinicalTrials.gov

US Benchmarking Clinical Study

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

September 16, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
HFpEF - Heart Failure With Preserved Ejection FractionHFmrEFATTR-CM (Transthyretin Amyloid Cardiomyopathy)Left Ventricular HypertrophyCardiac Amyloidosis
Trial Locations (3)

02114

RECRUITING

Massachusetts General Hospital, Boston

02116

RECRUITING

Brigham and Women's Hospital, Boston

02118

RECRUITING

Boston Medical Center, Boston

Sponsors

Collaborators (1)

Boston Medical Center
All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Boston Medical Center

OTHER

lead

eMyosound SAS

INDUSTRY

NCT07215715 - US Benchmarking Clinical Study | Biotech Hunter | Biotech Hunter